Huiying Chi

862 total citations
15 papers, 696 citations indexed

About

Huiying Chi is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Huiying Chi has authored 15 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Huiying Chi's work include Cancer-related molecular mechanisms research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Cancer Risks and Factors (2 papers). Huiying Chi is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Cancer Risks and Factors (2 papers). Huiying Chi collaborates with scholars based in China and United States. Huiying Chi's co-authors include Te Liu, Jiulin Chen, Chuan Chen, Yongyi Huang, Zhihua Yu, Zhiqiang Meng, Chenyue Zhang, Jian Zhang, Wenxing Qin and Haiyong Wang and has published in prestigious journals such as Gene, Oncotarget and International Journal of Oncology.

In The Last Decade

Huiying Chi

15 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiying Chi China 11 446 298 134 87 71 15 696
Yun Zhou China 16 367 0.8× 84 0.3× 39 0.3× 105 1.2× 26 0.4× 45 632
Zhao Wu China 13 350 0.8× 96 0.3× 24 0.2× 80 0.9× 32 0.5× 38 638
Ye Leng China 11 559 1.3× 224 0.8× 45 0.3× 84 1.0× 8 0.1× 22 774
L. Ravenna Italy 15 346 0.8× 172 0.6× 17 0.1× 87 1.0× 71 1.0× 24 684
Herman Depypere Belgium 12 170 0.4× 129 0.4× 36 0.3× 37 0.4× 26 0.4× 20 501
Zan Fu China 18 387 0.9× 203 0.7× 20 0.1× 105 1.2× 26 0.4× 50 761
Bing Wei China 15 408 0.9× 283 0.9× 22 0.2× 41 0.5× 10 0.1× 33 622

Countries citing papers authored by Huiying Chi

Since Specialization
Citations

This map shows the geographic impact of Huiying Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiying Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiying Chi more than expected).

Fields of papers citing papers by Huiying Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiying Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiying Chi. The network helps show where Huiying Chi may publish in the future.

Co-authorship network of co-authors of Huiying Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Huiying Chi. A scholar is included among the top collaborators of Huiying Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiying Chi. Huiying Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chi, Huiying, Te Liu, Weidong Pan, et al.. (2019). Shen-Zhi-Ling oral solution improves learning and memory ability in Alzheimer's disease mouse model.. PubMed. 39(5). 667–677. 3 indexed citations
2.
Wang, Xiaohui, et al.. (2018). How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study. OncoTargets and Therapy. Volume 11. 1005–1011. 2 indexed citations
3.
Wang, Haiyong, Chenyue Zhang, Huiying Chi, & Zhiqiang Meng. (2018). Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling. International Journal of Oncology. 52(6). 2051–2060. 32 indexed citations
4.
Wang, Haiyong, Chenyue Zhang, Huiying Chi, & Zhiqiang Meng. (2018). Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins. Molecular Medicine Reports. 17(6). 8101–8110. 10 indexed citations
5.
Liu, Te, Huiying Chi, Jiulin Chen, et al.. (2017). Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene. 631. 29–38. 123 indexed citations
6.
Xing, Sanli, et al.. (2017). Effect of the herbal formulation Shen-Zhi-Ling on an APP/PS1 mouse model of Alzheimer's disease by modulating the biliverdin reductase/heme oxygenase 1 system. Experimental and Therapeutic Medicine. 14(3). 1961–1966. 7 indexed citations
7.
Sun, Lin, Fangfang Dou, Jiulin Chen, et al.. (2017). Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model. Molecular Medicine Reports. 17(1). 257–263. 23 indexed citations
8.
Chi, Huiying, Chenyue Zhang, Haiyong Wang, & Zhehai Wang. (2017). The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study. Oncotarget. 8(39). 65668–65676. 4 indexed citations
9.
10.
Wang, Haiyong, Chenyue Zhang, Litao Xu, et al.. (2016). Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. Oncotarget. 7(15). 20193–20208. 98 indexed citations
11.
Wang, Yun, Weidong Pan, Huiying Chi, et al.. (2015). Small molecule compounds alleviate anisomycin-induced oxidative stress injury in SH-SY5Y cells via downregulation of p66shc and Aβ1–42 expression. Experimental and Therapeutic Medicine. 11(2). 593–600. 15 indexed citations
12.
Liu, Te, Yongyi Huang, Jian Zhang, et al.. (2014). Transplantation of Human Menstrual Blood Stem Cells to Treat Premature Ovarian Failure in Mouse Model. Stem Cells and Development. 23(13). 1548–1557. 146 indexed citations
13.
Wang, Haiyong, Litao Xu, Xiaoyan Zhu, et al.. (2014). Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma. Oncology Reports. 32(4). 1465–1472. 33 indexed citations
14.
Liu, Te, Yongyi Huang, Jiulin Chen, et al.. (2014). Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression. Molecular Medicine Reports. 10(3). 1275–1281. 87 indexed citations
15.
Liu, Te, Dingzhu Shen, Jiulin Chen, et al.. (2012). Attenuation of exogenous angiotensin II stress-induced damage and apoptosis in human vascular endothelial cells via microRNA-155 expression. International Journal of Molecular Medicine. 31(1). 188–196. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Zhou Breakdown of academic impact, for papers by Zhao Wu Breakdown of academic impact, for papers by Ye Leng Breakdown of academic impact, for papers by L. Ravenna Breakdown of academic impact, for papers by Herman Depypere Breakdown of academic impact, for papers by Zan Fu Breakdown of academic impact, for papers by Bing Wei
Rankless by CCL
2026